Postdoctoral Researcher / PhD Candidate Position

Postdoctoral Researcher / PhD Candidate Position

Cardiac targeting of connexin-43 with a mimetic peptide to reduce infarct size

Organisation: Inserm
Research area: biology › cell biology › cardiovascular physiology

Required profile: postdoctoral researcher or doctoral candidate

Location: France › Paris-Saclay University, Faculty of Pharmacy › Orsay – Inserm UMR-S1180

Type of contract: Temporary – for postdoctoral: 1 year (renewable for 1 year) or 3 years for doctoral candidate

Status: Full-time – 35 hours
Start date: Early 2026

Salary: Salary will be determined based on years of postgraduate experience, in accordance with the institution’s guidelines. Benefits included in accordance with Inserm guidelines.

Share this post

Twitter
Facebook
LinkedIn
WhatsApp

Latest Updates

Postdoctoral Position in Paris

WG4 METAHEART CA Webinar

From Omics to Mechanisms: Mechano-Energetic Uncoupling in Heart Failure

Newsletter

Subscribe our Newsletter and stay up-to-date

Stay Up-to-date

Guido Kroemer’s team in Paris is seeking to recruit outstanding postdoctoral fellows with strong expertise in molecular and cellular biology, immunology, and/or physiology to investigate the role of ACBP/DBI, a...
May 19th, 13.00 London Time, 14.00 Berlin Time Hosts: Prof Dunja Aksentijevic (UK) WG4 lead, Prof Simon Sedej (Austria) & Dr Edoardo Bertero (Italy) WG4 Deputy Leads
Wednesday 22nd April, 12.00 GMTJoin us on Zoom – click here to register. Hosts: Prof Dunja Aksentijevic (UK) WG4 lead, Prof Simon Sedej (Austria) &Dr Edoardo Bertero (Italy) WG4 Deputy...
📆 Deadline: Submission for applications is open until May 1, 2026. 🤝 Work together, exchange technology & build new scientific collaborations within EU-METAHEART COST Action. ➡️ STSMs are THE way to...
Save-the-Date AMPK 2026
📍 Lunteren, Netherlands📅 27–29 September 2026This 3-day meeting will bring together leading experts and early-career researchers to discuss the latest advances in AMPK signaling, nutrient sensing pathways, and their roles...
👏 Congratulations to our EU-METAHEART COST Action WG4 leader Dunja Aksentijevic Ricciarelli for the publication of her new study in Nature Cardiovascular Research: https://lnkd.in/db3WWu_Q💡 “Targeting immunometabolic pathways with AZD1656 alleviates inflammation and metabolic dysfunction in type 2...